motexafin-lutetium and temoporfin

motexafin-lutetium has been researched along with temoporfin* in 1 studies

Reviews

1 review(s) available for motexafin-lutetium and temoporfin

Article	Year
Photodynamic therapy for focal ablation of the prostate. World journal of urology, 2010, Volume: 28, Issue:5 Although in early stages of clinical development, photodynamic therapy (PDT) shows promise in delivering focal treatment of both primary and post-radiotherapy prostate cancer. This article will review the mechanism of action of PDT, previous research using PDT for treating prostate cancer including the development of newer vascular-acting photosensitizers, and the potential advantages and disadvantages of PDT in delivering focal therapy. Topics: Dihematoporphyrin Ether; Humans; Male; Mesoporphyrins; Metalloporphyrins; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Treatment Outcome	2010

Article

Year

Photodynamic therapy for focal ablation of the prostate.

World journal of urology, 2010, Volume: 28, Issue:5

Although in early stages of clinical development, photodynamic therapy (PDT) shows promise in delivering focal treatment of both primary and post-radiotherapy prostate cancer. This article will review the mechanism of action of PDT, previous research using PDT for treating prostate cancer including the development of newer vascular-acting photosensitizers, and the potential advantages and disadvantages of PDT in delivering focal therapy.

Topics: Dihematoporphyrin Ether; Humans; Male; Mesoporphyrins; Metalloporphyrins; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Treatment Outcome

2010